Versius Connect
Near-real-time procedural logbook app for surgeons
Company profile
Company profile
CMR Surgical is a global medical technology company that has developed the Versius Surgical Robotic System, a next-generation surgical robot designed to expand access to robotic-assisted surgery across all care settings. The company's flagship product, Versius Plus, is a compact, modular, and portable surgical robot that fits into virtually any operating room without requiring dedicated space or infrastructure modifications. Unlike traditional large surgical robots, Versius is designed with adaptability at its core, allowing hospitals to seamlessly switch between robotic and non-robotic procedures in the same space and enabling easy movement between departments and operating rooms. The system supports familiar port placement, allowing surgeons to build on their existing laparoscopic knowledge and rapidly achieve proficiency with surgical robotics. Versius Plus features an integrated fluorescence visualization system called vLimeLite for real-time ICG imaging, a full suite of articulated instruments, and a comprehensive digital ecosystem that includes Versius Connect for surgeons and Versius Team for hospital administrators. These digital tools provide near-real-time procedural data, usage tracking, and operational insights to optimize robotic surgery programs. CMR Surgical has achieved significant clinical adoption, with over 45,000 procedures performed globally, making Versius the second most utilized robotic surgical platform worldwide. The company has received FDA 510(k) clearance for cholecystectomy procedures in the United States and has submitted for gynecology indications. Versius is also approved for use across Europe, Australia, and Brazil. CMR Surgical's approach emphasizes partnership with surgical teams, offering evidence-based implementation support backed by clinical research and a mature digital ecosystem. The company's mission centers on putting patients first in every decision, working to democratize access to the benefits of minimal access surgery through innovative, accessible robotic technology.
Company description CMR Surgical official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Embedded · On Premise deployment with recorded integration context.
Company milestones
FDA 510(k) clearance for Versius Plus cholecystectomy (December 2025), 510(k) submission for gynecology indications (April 2026), 45,000 global procedures milestone (March 2026), U.S. market entry (2025-2026)
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Near-real-time procedural logbook app for surgeons
Comprehensive digital platform for actionable surgical data and insights
Next generation surgical robot for versatile, adaptable robotic-assisted surgery
Small, modular & portable surgical robot for minimal access surgery
Live dashboard for tracking robotic program usage and efficiency
Integrated fluorescence visualization system with real-time ICG imaging
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
The international journal of medical robotics + computer assisted surgery : MRCAS · Apr 1, 2026
Collagen-Electrohydrodynamic Hierarchical Lithography for Biomimetic Photonic Micro-Nanomaterials.Small (Weinheim an der Bergstrasse, Germany) · Oct 1, 2024
Partial nephrectomy series using Versius robotic surgical system: technique and outcomes of an initial experience.Journal of robotic surgery · Feb 13, 2024
Versius robotic surgical system: case series of 18 robot-assisted radical prostatectomies.BJU international · Feb 1, 2024
Technical and ethical considerations in telesurgery.Journal of robotic surgery · Jan 17, 2024
New robotic platform for transoral robotic surgery: an IDEAL stage 0 study.BMJ surgery, interventions, & health technologies · Jan 1, 2024
Clinical validation
NCT07761299 · Sponsor · NOT YET RECRUITING
Versius Clinical Study in Robot Assisted Inguinal Hernia Repair SurgeryNCT07316517 · Sponsor · NOT YET RECRUITING
Versius Gynecology StudyNCT07289295 · Sponsor · RECRUITING
Post Market Clinical Study to Evaluate the Performance of the Versius Surgical SystemNCT07096856 · Sponsor · NOT YET RECRUITING
Prospective Clinical Study to Assess the Safety and Efficacy of Versius, in Transoral Robotic SurgeryNCT06112535 · Sponsor · COMPLETED
Versius Paediatrics StudyNCT06539442 · Sponsor · RECRUITING
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Clinical adoption milestone as of March 2026
Market position as of March 2026
Deployment of Versius surgical robotic system across multiple procedures and specialties
45,000+ procedures performed globally, second most utilized robotic surgical platform worldwide
Implementation of Versius robotic surgical system for various procedures
Introduction of surgical robotics research through clinical studies with Versius
Hospital remains at forefront of innovation with two new clinical studies
05 · Leadership
Leadership profiles and professional links from the current Company record.
Massimillano Colella
Chief Executive Officer
Mario Nosotti
Thoracic Surgeon
Pradeep Chowbey
General Surgeon
Nidhi Singh
Gynecology Surgeon
Vanash Patel
Colorectal Surgeon
Steven Le Gouill
Professor
06 · Company updates
Recent articles published on CMR Surgical's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.